Barclays initiates Sutro Biopharma stock with overweight rating

Markets Investing.com By Investing.com 28 May 2026 08:31 1 min read

Barclays initiates Sutro Biopharma stock with overweight rating

Barclays initiates Sutro Biopharma stock with overweight rating

Barclays initiates Sutro Biopharma stock with overweight rating

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.